LEVITRA® 20mg Special Drug Use Investigation (Long-term)

Bayer

Status: Completed

Conditions: Erectile Dysfunction

Treatments: Drug: Vardenafil, (Levitra, BAY38-9456)

Study type: Observational

Funder types: Industry

Identifiers

NCT00909233

13930

LV0701JP

Details and patient eligibility

About

This investigation targets either the patients of 18 years-old or older and under 65 years-old with organic or mixed erectile dysfunction (ED) who cannot obtain sufficient efficacy by dose 10mg of Levitra, and the target patients dose is increased to Levitra 20mg. This investigation will be limited to the patients whose tolerability of Levitra 10mg is judged to be no problem.

Enrollment: 1,221 patients

Sex: Male

Ages: 18 to 64 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• This investigation targets either the patients of 18 years-old or older and under 65 years-old with organic or mixed erectile dysfunction who cannot obtain sufficient efficacy by dose 10mg of Levitra, and the target patients dose is increased to Levitra 20mg. This investigation will be limited to the patients whose tolerability of Levitra 10mg is judged to be no problem.

Trial design

1,221 participants in 1 patient group

Group 1

Treatment:

Drug: Vardenafil, (Levitra, BAY38-9456)